Why Look for Cures?
Despite vaccines' excellent track record, most Big Pharma companies that pursued other avenues of attack find themselves
in the difficult position of commercializing antibiotics that have been made virtually impotent by the constant mutation and
evolution of the hardiest of the planet's inhabitants. Even the CDC, in its recently released "Public Action Plan to Combat
Antimicrobial Resistance," emphasizes the urgent need for better education in dealing with the misuse of antibiotics. And
while that worrisome to Nabi's leaders and workforce, it's not their main concern. To illustrate their focus, Jooste asks
a simple question: "Why bother looking for a cure when you can prevent it in the first place?" As obvious as that sounds,
Nabi's on to something big. Like a Jackson Pollock painting, people look at it and think, "I could have done that." But, they
didn't—Nabi did.
Sibyl Shalo, senior editor, manages the editorial direction and content of Media Mix, Pharmaceutical Executive's marketing and media section. Sibyl's extensive healthcare experience includes writing, editing, media and government relations, medical education, and marketing communications. Her career has taken her from Washington, DC, where she wore many hats at the National Alliance for the Mentally Ill, to her hometown of New York, where she worked as a freelance medical writer and media liaison for leading public relations agencies. She held positions at New York University Medical Center and Memorial Sloan-Kettering Cancer Center before freelancing with Reuters Health. She made the full-time switch to journalism with Pharmaceutical Executive in September 2000.
Articles by Sibyl Shalo
PharmExec Blog
Follow Us
RSS
Bookstore
